Changes in urinary catecholamines and their metabolites in depressed patients treated with amitriptyline or imipramine

Charles L. Bowden, Stephen Koslow, James W. Maas, John Davis, David L. Garver, Israel Hanin

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The effects of treatment with amitriptyline (AMI) or imipramine (IMI) on changes in catecholamines and their metabolites in urine were studied in 95 unipolar and bipolar depressed patients. For the entire group, not separated by drug, substantial reduction in concentrations of all metabolites, but not catecholamines, occurred. Although catecholamine and metabolite change was similar for most substances assayed, there were some specific drug and diagnostic group differences. Vanillylmandelic acid (VMA) reduction was limited to bipolar patients; metanephrine (M) reduction to unipolar patients. Greater M and 3-methoxy-4-hydroxyphenylglycol (MHPG) reduction were associated with response in unipolar, but not bipolar patients. In bipolar, but not unipolar patients, norepinephrine (NE) rose in responders in contrast to reductions among nonresponding bipolar patients. The results suggest that effectiveness of blockade of reuptake of norepinephrine may be relatively more important for recovery in bipolar than in unipolar patients. Study of a battery of amine substances may contribute more information to our understanding of antidepressant drug effects on aminergic systems than analyses of MHPG alone.

Original languageEnglish (US)
Pages (from-to)111-128
Number of pages18
JournalJournal of Psychiatric Research
Volume21
Issue number2
DOIs
StatePublished - 1987
Externally publishedYes

Fingerprint

Amitriptyline
Imipramine
Catecholamines
Norepinephrine
Vanilmandelic Acid
Metanephrine
Systems Analysis
Pharmaceutical Preparations
Antidepressive Agents
Amines
Urine

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry
  • Psychology(all)

Cite this

Changes in urinary catecholamines and their metabolites in depressed patients treated with amitriptyline or imipramine. / Bowden, Charles L.; Koslow, Stephen; Maas, James W.; Davis, John; Garver, David L.; Hanin, Israel.

In: Journal of Psychiatric Research, Vol. 21, No. 2, 1987, p. 111-128.

Research output: Contribution to journalArticle

Bowden, Charles L. ; Koslow, Stephen ; Maas, James W. ; Davis, John ; Garver, David L. ; Hanin, Israel. / Changes in urinary catecholamines and their metabolites in depressed patients treated with amitriptyline or imipramine. In: Journal of Psychiatric Research. 1987 ; Vol. 21, No. 2. pp. 111-128.
@article{31f5e73a855646b9a42b72d1dee05bc8,
title = "Changes in urinary catecholamines and their metabolites in depressed patients treated with amitriptyline or imipramine",
abstract = "The effects of treatment with amitriptyline (AMI) or imipramine (IMI) on changes in catecholamines and their metabolites in urine were studied in 95 unipolar and bipolar depressed patients. For the entire group, not separated by drug, substantial reduction in concentrations of all metabolites, but not catecholamines, occurred. Although catecholamine and metabolite change was similar for most substances assayed, there were some specific drug and diagnostic group differences. Vanillylmandelic acid (VMA) reduction was limited to bipolar patients; metanephrine (M) reduction to unipolar patients. Greater M and 3-methoxy-4-hydroxyphenylglycol (MHPG) reduction were associated with response in unipolar, but not bipolar patients. In bipolar, but not unipolar patients, norepinephrine (NE) rose in responders in contrast to reductions among nonresponding bipolar patients. The results suggest that effectiveness of blockade of reuptake of norepinephrine may be relatively more important for recovery in bipolar than in unipolar patients. Study of a battery of amine substances may contribute more information to our understanding of antidepressant drug effects on aminergic systems than analyses of MHPG alone.",
author = "Bowden, {Charles L.} and Stephen Koslow and Maas, {James W.} and John Davis and Garver, {David L.} and Israel Hanin",
year = "1987",
doi = "10.1016/0022-3956(87)90012-4",
language = "English (US)",
volume = "21",
pages = "111--128",
journal = "Journal of Psychiatric Research",
issn = "0022-3956",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Changes in urinary catecholamines and their metabolites in depressed patients treated with amitriptyline or imipramine

AU - Bowden, Charles L.

AU - Koslow, Stephen

AU - Maas, James W.

AU - Davis, John

AU - Garver, David L.

AU - Hanin, Israel

PY - 1987

Y1 - 1987

N2 - The effects of treatment with amitriptyline (AMI) or imipramine (IMI) on changes in catecholamines and their metabolites in urine were studied in 95 unipolar and bipolar depressed patients. For the entire group, not separated by drug, substantial reduction in concentrations of all metabolites, but not catecholamines, occurred. Although catecholamine and metabolite change was similar for most substances assayed, there were some specific drug and diagnostic group differences. Vanillylmandelic acid (VMA) reduction was limited to bipolar patients; metanephrine (M) reduction to unipolar patients. Greater M and 3-methoxy-4-hydroxyphenylglycol (MHPG) reduction were associated with response in unipolar, but not bipolar patients. In bipolar, but not unipolar patients, norepinephrine (NE) rose in responders in contrast to reductions among nonresponding bipolar patients. The results suggest that effectiveness of blockade of reuptake of norepinephrine may be relatively more important for recovery in bipolar than in unipolar patients. Study of a battery of amine substances may contribute more information to our understanding of antidepressant drug effects on aminergic systems than analyses of MHPG alone.

AB - The effects of treatment with amitriptyline (AMI) or imipramine (IMI) on changes in catecholamines and their metabolites in urine were studied in 95 unipolar and bipolar depressed patients. For the entire group, not separated by drug, substantial reduction in concentrations of all metabolites, but not catecholamines, occurred. Although catecholamine and metabolite change was similar for most substances assayed, there were some specific drug and diagnostic group differences. Vanillylmandelic acid (VMA) reduction was limited to bipolar patients; metanephrine (M) reduction to unipolar patients. Greater M and 3-methoxy-4-hydroxyphenylglycol (MHPG) reduction were associated with response in unipolar, but not bipolar patients. In bipolar, but not unipolar patients, norepinephrine (NE) rose in responders in contrast to reductions among nonresponding bipolar patients. The results suggest that effectiveness of blockade of reuptake of norepinephrine may be relatively more important for recovery in bipolar than in unipolar patients. Study of a battery of amine substances may contribute more information to our understanding of antidepressant drug effects on aminergic systems than analyses of MHPG alone.

UR - http://www.scopus.com/inward/record.url?scp=0023248629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023248629&partnerID=8YFLogxK

U2 - 10.1016/0022-3956(87)90012-4

DO - 10.1016/0022-3956(87)90012-4

M3 - Article

C2 - 3295209

AN - SCOPUS:0023248629

VL - 21

SP - 111

EP - 128

JO - Journal of Psychiatric Research

JF - Journal of Psychiatric Research

SN - 0022-3956

IS - 2

ER -